Adimmune Corp (4142) - Total Liabilities

Latest as of September 2025: NT$3.53 Billion TWD ≈ $111.13 Million USD

Based on the latest financial reports, Adimmune Corp (4142) has total liabilities worth NT$3.53 Billion TWD (≈ $111.13 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 4142 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Adimmune Corp - Total Liabilities Trend (2007–2024)

This chart illustrates how Adimmune Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 4142 total assets.

Adimmune Corp Competitors by Total Liabilities

The table below lists competitors of Adimmune Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Hyundai Cement KO:006390	Korea	₩469.22 Billion
High Tide Inc V:HITI	Canada	CA$245.96 Million
Astral Resources NL AU:AAR	Australia	AU$4.92 Million
Jaya Tiasa Holdings Bhd KLSE:4383	Malaysia	RM362.93 Million
Warriedar Resources Ltd AU:WA8	Australia	AU$16.84 Million
Transimex Saigon Corp VN:TMS	Vietnam	₫3.50 Trillion
Metropolitan Land Tbk JK:MTLA	Indonesia	Rp2.24 Trillion

Liability Composition Analysis (2007–2024)

This chart breaks down Adimmune Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 4142 net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.75	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Adimmune Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Adimmune Corp (2007–2024)

The table below shows the annual total liabilities of Adimmune Corp from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$2.92 Billion ≈ $91.99 Million	-21.23%
2023-12-31	NT$3.71 Billion ≈ $116.79 Million	+42.37%
2022-12-31	NT$2.60 Billion ≈ $82.03 Million	+65.05%
2021-12-31	NT$1.58 Billion ≈ $49.70 Million	-14.48%
2020-12-31	NT$1.84 Billion ≈ $58.12 Million	-32.79%
2019-12-31	NT$2.74 Billion ≈ $86.47 Million	-28.19%
2018-12-31	NT$3.82 Billion ≈ $120.41 Million	+12.53%
2017-12-31	NT$3.40 Billion ≈ $107.01 Million	-7.95%
2016-12-31	NT$3.69 Billion ≈ $116.25 Million	+110.90%
2015-12-31	NT$1.75 Billion ≈ $55.12 Million	+25.90%
2014-12-31	NT$1.39 Billion ≈ $43.78 Million	-38.22%
2013-12-31	NT$2.25 Billion ≈ $70.87 Million	-0.05%
2012-12-31	NT$2.25 Billion ≈ $70.91 Million	+11.97%
2011-12-31	NT$2.01 Billion ≈ $63.33 Million	+48.38%
2010-12-31	NT$1.35 Billion ≈ $42.68 Million	-30.24%
2009-12-31	NT$1.94 Billion ≈ $61.18 Million	+89.58%
2008-12-31	NT$1.02 Billion ≈ $32.27 Million	+367.95%
2007-12-31	NT$218.90 Million ≈ $6.90 Million	--

About Adimmune Corp

TW:4142 Taiwan Biotechnology

Market Cap

$235.72 Million

NT$7.48 Billion TWD

Market Cap Rank

#16001 Global

#732 in Taiwan

Share Price

NT$17.75

Change (1 day)

+2.90%

52-Week Range

NT$16.55 - NT$21.55

All Time High

NT$77.19